Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth…
CALGARY, AB, Oct. 7, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable…
LEXINGTON, Ky., Oct. 7, 2025 /PRNewswire/ -- TruDiagnostic, a leader in epigenetic testing and health analytics, announced today it has…
PENSACOLA, Fla., Oct. 7, 2025 /PRNewswire/ -- Circulogene today announced the national launch of OncoGenDx, an innovative tissue-based comprehensive genomic…
Findings show that Telomir-1 restores the body's natural tumor suppressor defenses by reversing abnormal DNA methylation of MASPIN and RASSF1A…
Oral presentation will include the full 96-week and post-treatment follow up data from the Phase 1 monotherapy study of ALG-000184SOUTH…
Strengthens Balance Sheet with Over $60 Million in Cash1, Excluding Bitcoin TreasuryDavid Beckham Co-Founded IM8 on Track to Achieve $100…
NORCROSS, Ga., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3…
BROOKLYN, N.Y., Oct. 6, 2025 /PRNewswire/ -- Virtual Field, the inventor of virtual reality visual field (VRVF) technology in modern…
Goal of POSEIDON is to enable accurate, low-cost, accessible cancer screening for all Americans Program to deliver first-in-class synthetic-sensor based…